tiprankstipranks
VOR Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsVOR Upcoming Earnings Report: What to Expect?
1M ago
Vor Bio treatment of acute myeloid leukemia granted FDA orphan designation
PremiumThe Fly
Vor Bio treatment of acute myeloid leukemia granted FDA orphan designation
1M ago
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2M ago
Vor Bio Doses First AML Patient with VCAR33 (ALLO) and Provides Corporate Update
PremiumPress ReleasesVor Bio Doses First AML Patient with VCAR33 (ALLO) and Provides Corporate Update
3M ago
Vor Bio extended cash runway into 2H25
PremiumThe Fly
Vor Bio extended cash runway into 2H25
3M ago
Vor Bio doses first AML patient with VCAR33  or ALLO
PremiumThe Fly
Vor Bio doses first AML patient with VCAR33 or ALLO
3M ago
Oppenheimer biotechnology analyst to hold an analyst/industry conference call
PremiumThe FlyOppenheimer biotechnology analyst to hold an analyst/industry conference call
6M ago
Vor Bio Reports Third Quarter 2023 Financial Results and Provides Company Update
PremiumPress Releases
Vor Bio Reports Third Quarter 2023 Financial Results and Provides Company Update
6M ago
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100